Hoda Hassab

A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease

Elliott Vichinsky, Carolyn Hoppe, Kenneth I. Ataga et al. · New England Journal of Medicine · 2019 · 609 citations · Full text

Medicine, Hematology, Hematopathology +8

A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events

Matthew M. Heeney, Carolyn Hoppe, Miguel R. Abboud et al. · New England Journal of Medicine · 2015 · 145 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial

Jo Howard, Kenneth I. Ataga, Robert C. Brown et al. · The Lancet Haematology · 2021 · 101 citations

Medicine, Health Sciences, Hematology +5

Evaluation of the efficacy and safety of deferiprone compared with deferasirox in paediatric patients with transfusion-dependent haemoglobinopathies (DEEP-2): a multicentre, randomised, open-label, non-inferiority, phase 3 trial

Aurelio Maggio, Antonis Kattamis, Mariagrazia Felisi et al. · The Lancet Haematology · 2020 · 72 citations

Medicine, Pediatrics, Pharmacology +11

National survey of the oral health of 5-year-old children in the United Arab Emirates

M.A.I. El Nadeef, Hoda Hassab, E. Al Hosani · Eastern Mediterranean Health Journal · 2010 · 61 citations · Full text

Dentistry, Dental Public Health, Oral Health Sciences +17